首页> 外国专利> compound, salts, solvates and solvates of the salts of the compounds, drug, method for treatment or prophylaxis of thrombotic diseases, stroke, cardiac infarction or atrial fibrillation and cardiac arrhythmia in humans or animals, method for treatment or prophylaxis of oncological diseases in humans or animals and method for preparing a compound

compound, salts, solvates and solvates of the salts of the compounds, drug, method for treatment or prophylaxis of thrombotic diseases, stroke, cardiac infarction or atrial fibrillation and cardiac arrhythmia in humans or animals, method for treatment or prophylaxis of oncological diseases in humans or animals and method for preparing a compound

机译:化合物,化合物的盐,溶剂化物和盐的溶剂化物,药物,人或动物的血栓性疾病,中风,心脏梗塞或房颤和心律不齐的治疗或预防方法,人的肿瘤疾病的治疗或预防方法或动物以及制备化合物的方法

摘要

summary “compound, salts, solvates and solvates of the salts of the compounds, drug, method for treatment or prophylaxis of thrombotic diseases, stroke, cardiac infarction or atrial fibrillation and cardiac arrhythmia in humans or animals, method for treatment or prophylaxis of oncological diseases in humans. or Animals and Method for Preparing a Compound ”The present invention relates to dabigatran prodrug derivatives, their use in the treatment and / or prophylaxis of diseases, in particular thrombotic diseases, stroke, cardiac infarction and / or atrial fibrillation and arrhythmia as well as oncological diseases of any pathogenesis.
机译:概述“化合物,化合物的盐,溶剂化物和盐的溶剂化物,药物,人或动物的血栓性疾病,中风,心梗或房颤和心律不齐的治疗或预防方法,肿瘤病的治疗或预防方法在人类中。或本发明涉及达比加群前药衍生物,其在疾病的治疗和/或预防中的用途,特别是血栓性疾病,中风,心脏梗塞和/或房颤和心律失常以及肿瘤治疗任何发病机制的疾病。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号